Results 151 to 160 of about 168,658 (234)

In-vitro interaction studies between the amyloid PET tracer florbetaben and the amyloid-beta targeting antibodies lecanemab and donanemab on AD brain samples reveal no interferences. [PDF]

Alzheimers Res Ther
Mueller A, Jovalekic A, Chapleau M, Seidel J, Ritter M, Bickel EM, Kiessling N, MacSweeney E, Stephens AW, Koglin N.   +9 more
europepmc   +1 more source

Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases. [PDF]

Int J Mol Sci
Bougea A.
europepmc   +1 more source

From Traumatic Brain Injury to Alzheimer's Disease: Multilevel Biomechanical, Neurovascular, and Molecular Mechanisms with Emerging Therapeutic Directions. [PDF]

Int J Mol Sci
Katramadou A, Bender ES, Kanakis D.
europepmc   +1 more source

Application of machine learning to blood-based biomarkers of Alzheimer's disease in Down syndrome. [PDF]

Alzheimers Dement (Amst)
Luckett PH, Petersen M, O'Bryant S, Mapstone M, Christian BT, Handen B, Head E, Ances BM, Alzheimer's Biomarker Consortium‐Down Syndrome.   +8 more
europepmc   +1 more source